Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Vice President Mike Pence (C) speaks at the White House Monday, flanked by (L to R) senior health officials Robert Redfield, Dr. Anthony Fauci, Debbie Birx, Seema Verma, Alex Azar and Stephen Hahn. Photo: Drew Angerer/Getty Images

Food and Drug Administration commissioner Stephen Hahn told a news conference Monday that health officials should be able to perform nearly 1 million tests for the novel coronavirus by the end of the week.

Why it matters: Officials in the U.S. and around the world are scrambling to combat a rise in cases of COVID-19.

The estimates that we’re getting from industry right now, by the end of this week close to 1 million tests will be able to be performed."
— Stephen Hahn at the news conference
  • Hahn's remarks come as the Trump administration has ordered an independent investigation after a top federal scientist raised concerns about possible contamination in a CDC lab in Atlanta where the government made test kits for the coronavirus, as first reported by Axios.

By the numbers: The CDC said in a statement Monday there were 91 confirmed and presumptive coronavirus cases in the U.S., but this was before more cases were announced in Washington state and Georgia — taking the number of infections past 100.

What they're saying: Hahn said at the news conference he expected to see a "substantial increase" in the number of tests because of a new policy enabling regulatory flexibility so academic centers and private firms could develop and verify tests for public use quicker "this week, next week and throughout the month."

  • Vice President Mike Pence, who's leading the Trump administration's coronavirus task force, stressed at the news conference that despite the rise of infections in the U.S., the risk of contracting the virus remains low.
  • "We're focused on mitigation of the spread, as well as the treatment of the people affected," Pence said.

Go deeper: Lab for coronavirus test kits may have been contaminated

Go deeper

2 hours ago - Health

Food banks feel the strain without holiday volunteers

People wait in line at Food Bank Community Kitchen on Nov. 25 in New York City. Photo: Michael Loccisano/Getty Images for Food Bank For New York City

America's food banks are sounding the alarm during this unprecedented holiday season.

The big picture: Soup kitchens and charities, usually brimming with holiday volunteers, are getting far less help.

4 hours ago - Health

AstraZeneca CEO: "We need to do an additional study" on COVID vaccine

Photo: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

AstraZeneca CEO Pascal Soriot said on Thursday the company is likely to start a new global trial to measure how effective its coronavirus vaccine is, Bloomberg reports.

Why it matters: Following Phase 3 trials, Oxford and AstraZeneca said their vaccine was 90% effective in people who got a half dose followed by a full dose, and 62% effective in people who got two full doses.

Updated 7 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: Coronavirus cases rose 10% in the week before Thanksgiving.
  2. Politics: Supreme Court backs religious groups on New York coronavirus restrictions.
  3. World: Expert says COVID vaccine likely won't be available in Africa until Q2 of 2021 — Europeans extend lockdowns.
  4. Economy: The winners and losers of the COVID holiday season.
  5. Education: National standardized tests delayed until 2022.